The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helmby, H.
Right arrow Articles by Grencis, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helmby, H.
Right arrow Articles by Grencis, R. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2002, 169: 2553-2560.
Copyright © 2002 by The American Association of Immunologists

IL-18 Regulates Intestinal Mastocytosis and Th2 Cytokine Production Independently of IFN-{gamma} During Trichinella spiralis Infection1

Helena Helmby2 and Richard K. Grencis

School of Biological Sciences, University of Manchester, Manchester, United Kingdom


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Expulsion of the gastrointestinal nematode Trichinella spiralis is associated with pronounced mastocytosis mediated by a Th2-type response involving IL-4, IL-10, and IL-13. Here we demonstrate that IL-18 is a key negative regulator of protective immune responses against T. spiralis in vivo. IL-18 knockout mice are highly resistant to T. spiralis infection, expel the worms rapidly and subsequently develop low levels of encysted muscle larvae. The increased speed of expulsion is correlated with high numbers of mucosal mast cells and an increase in IL-13 and IL-10 secretion. When normal mice were treated with rIL-18 in vivo, worm expulsion was notably delayed, and the development of mastocytosis and Th2 cytokine production was significantly reduced. The treatment had no effect on intestinal eosinophilia or goblet cell hyperplasia but specifically inhibited the development of mastocytosis. Addition of rIL-18 to in vitro cultures of bone marrow-derived mast cells resulted in a significant reduction in cell yields as well as in the number of IL-4-secreting mast cells. In vivo treatment of T. spiralis-infected IFN-{gamma} knockout mice with rIL-18 demonstrated that the inhibitory effect of IL-18 on mastocytosis and Th2 cytokine secretion is independent of IFN-{gamma}. Hence, IL-18 plays a significant biological role as a negative regulator of intestinal mast cell responses and may promote the survival of intestinal parasites in vivo.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Gastrointestinal nematodes cause some of the most prevalent and chronic human diseases worldwide. CD4+ Th2 cells generated in the mesenteric lymph nodes (MLN)3 during the course of infection are critical in host-protective immunity to many intestinal nematodes, including Trichinella spiralis, a parasitic nematode that can infect almost all mammalian species (1). T. spiralis infects the small intestine, and adults release newborn larvae that penetrate the intestinal wall and subsequently encyst in skeletal muscle. The expulsion mechanism of adult T. spiralis worms from the small intestine is a complex immune-mediated process that involves the activation of Th2 cells and mucosal mast cells (MMC). A significant role for both MMC (2, 3, 4, 5) and Th2-type cytokines such as IL-9, IL-4, and IL-13 (6, 7, 8, 9) in the expulsion process of T. spiralis has been demonstrated in vivo.

It is well established that cytokines produced by Th1 and Th2 cells act antagonistically and mutually regulate each other. However, the critical question of which factors regulate the balance between Th1 and Th2 cytokines during the course of an immune response is still largely unresolved. IL-18 was originally named IFN-{gamma}-inducing factor (10) and is a potent inducer of IFN-{gamma}, particularly when acting in concert with IL-12 (10, 11, 12, 13). In mucosal defenses, IL-18 is believed to be proinflammatory and has been shown to be up-regulated in the intestinal mucosa of patients with inflammatory bowel disorders such as Crohn’s disease (14, 15) and in patients with Helicobacter infection (16). The main body of work regarding IL-18 has thus far been focused on the ability of this cytokine to induce IFN-{gamma} secretion, particularly together with IL-12. We have recently reported that IL-18 is essential for the development of chronic infection of the large intestine with the nematode Trichuris muris. Importantly, the critical effects of IL-18 in this infection are independent of IFN-{gamma} and are mediated by the direct down-regulatory effect of IL-18 on IL-13 (17), demonstrating that IL-18 exerts immunomodulatory functions that extend beyond the IL-12/IFN-{gamma} axis.

In this report, we provide new information on IL-18 as a key regulator of MMC development and Th2 responses in the small intestine. This study provides, for the first time, conclusive evidence that IL-18, without the help of IFN-{gamma}, has a direct effect on MMC responses and that IL-18 plays a significant role in the development of pathology caused by gastrointestinal nematode infections.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals and infections

Male NIH and C57BL/6 mice, 6–8 wk old, were purchased from Harlan Olac (Bicester, U.K.). Mice in which the IL-18 gene is disrupted (IL-18 knockout (KO) mice) were kindly provided by K. Takeda and S. Akira (18). IL-12 KO mice were originally provided by J. Magram (Hoffman-LaRoche, Nutley, NJ) (19), and IFN-{gamma} KO mice were originally purchased from The Jackson Laboratory (Bar Harbor, ME). All gene-deficient mice were on a C57BL/6 background. All experiments were performed under the regulations of the Home Office Scientific Procedures Act (1986).

Maintenance, infection, and recovery of T. spiralis were as described previously (20). Experimental mice were infected with 300 infective T. spiralis larvae by oral gavage on day 0, and the numbers of adult worms in the small intestine were assessed at various time points postinfection (p.i.) as detailed in the text. Muscle larvae burden were determined on day 30 p.i. T. spiralis Ag was prepared as described previously (1).

In vivo treatment with rIL-18 was performed by i.p. injections of 200 ng rIL-18 (PeproTech, London, U.K.) per mouse daily from day 0 to day 10 post-T. spiralis infection. Control mice received i.p. injections of PBS.

Cell culture and cytokine analysis

MLN were removed from uninfected and infected animals and resuspended in RPMI 1640 supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin, and 0.05 mM 2-ME (all from Invitrogen, Paisley, U.K.). MLN were cultured at 37°C and 5% CO2 in flat-bottom 96-well plates (Nunc, Roskilde, Denmark) at a final concentration of 5 x 106/ml in a final volume of 0.2 ml/well. Cells were stimulated with T. spiralis Ag (50 µg/ml) or plate-bound anti-CD3 Ab (mAb 145-2C11, 10 µg/ml; American Type Culture Collection, Manassas, VA). Anti-IL-4R mAb (M1, 5 µg/ml; from Dr. C. Maliszewski, Immunex, Seattle, WA) was added to cultures to increase detection of IL-4. Cell-free supernatants were harvested after 48 h and stored at -80°C.

Bone marrow-derived mast cells (BMMC) were generated by culturing bone marrow cells (0.5 x 106/ml) from femurs of naive 8-wk-old C57BL/6 mice for 25 days in culture medium supplemented with 20% WEHI-3-conditioned medium and various doses of rIL-18 (PeproTech). Nonadherent cells were transferred into new flasks every 7 days and suspended in fresh medium with or without added rIL-18. After 25 days in culture, the cells were 95% BMMC as determined by toluidine blue staining of cytospins (data not shown). The cells were carefully resuspended, washed three times, and counted using an automated cell counter (Casy 1 TT; Scharfe System, Reutlingen, Germany). The cells were then replated in either normal tissue culture plates (0.5 x 106/ml) or ELISPOT plates (104 cells/well) and cultured for an additional 24–48 h in the presence of 5 ng/ml PMA and 500 ng/ml ionomycin (both from Sigma-Aldrich, Gillingham, U.K.). Cell-free supernatants for the detection of MMC protease-1 (MMCP-1) levels were harvested after 48 h and stored at -80°C.

Cytokine ELISA and ELISPOT

Cytokine analyses were conducted using sandwich ELISAs for IL-4 (mAb BVC4-1D11 and BVD6-24G2.3; BD PharMingen, San Diego, CA) and IFN-{gamma} (R46A2 and XMG1.2; BD PharMingen). IL-13 and IL-10 were analyzed using Ab pairs from R&D Systems (Abingdon, U.K.). IL-4-producing BBMC cells were enumerated using an IL-4-ELISPOT kit (Mabtech, Nacka, Sweden).

MMCP-1 analysis

Serum and supernatant levels of MMCP-1 were determined using a commercially available kit (Moredun Animal Health, Penicuik, U.K.).

Histology

Consecutive lengths of small intestine taken 10 cm from the pyloric sphincter were fixed in Carnoy’s fluid or neutral buffered formalin and histologically processed using standard methods; 5-µm sections were stained for MMC (0.5% toluidine blue), goblet cells (periodic acid-Schiff), and eosinophils (H&E). The number of cells per 20 randomly selected villus crypt units were determined under light microscopy from at least two sections per animal.

RNase protection assay (RPA)

Total RNA was extracted from tissue specimens taken from the small intestine using Trizol (Invitrogen) according to the manufacturer’s instructions. A custom-made Riboquant template (BD PharMingen) was used to assay mRNA levels of IL-4, IL-13, IL-10, IL-9, IFN-{gamma}, and GAPDH. In vitro transcription with [32P]UTP (Amersham, Little Chalfont, U.K.) was performed using a Riboprobe kit (Promega, Southampton, U.K.) and T7 polymerase (Promega). From each sample, 10 µg of RNA were hybridized with the radiolabeled antisense RNA probe set, digested with RNases, and purified, and the protected probes were resolved on denaturing sequencing gels. Dried gels were exposed to phosphorimaging screens, and protected fragments were visualized using a Molecular Imager FX System (Bio-Rad Laboratories, Hertfordshire, U.K.). All samples were normalized with respect to the housekeeping gene GAPDH to ensure equal input of RNA.

Statistics

Significant differences (p < 0.05) between experimental groups were determined using the Mann-Whitney U test.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
IL-18 KO mice are more resistant to infection with T. spiralis than wild-type (WT) mice

The response of IL-18 KO mice to primary infections with T. spiralis was examined. KO mice and C57BL/6 WT mice were infected with 300 T. spiralis larvae, and worm burdens were assessed at days 8, 12, and 16 p.i. (n = 5). IL-18 KO mice had significantly reduced worm burdens by day 8 as compared with WT mice (p < 0.05) (Fig. 1GoA). The difference in expulsion kinetics was still apparent at days 12 and 16 p.i. when WT mice exhibited significant numbers of worms in the intestine while IL-18 KO mice had almost completed the expulsion process (p < 0.01) (Fig. 1GoA). IL-12 p40 KO mice were also infected in a parallel experiment, and these mice did not differ in their worm expulsion kinetics from the WT mice at any time point (Fig. 1GoA).



View larger version (22K):
[in this window]
[in a new window]
  		FIGURE 1. IL-18 KO mice are highly resistant to T. spiralis infection. A, WT, IL-18 KO, and IL-12p40 KO mice on a C57BL/6 background were inoculated orally with 300 T. spiralis muscle larvae. Mice were sacrificed, and adult worms were counted at the time points indicated. Mean and SEM are shown in this and all subsequent figures. Four to five mice were used per group in this and all subsequent experiments. B, WT, IL-18 KO, and IL-12p40 KO were inoculated as above, and the number of muscle larvae was determined 30 days later. *, Statistically significant difference between KO and WT (p < 0.05).

 
Skeletal muscle larvae burdens were assessed in the infected groups at 30 days p.i. The results revealed that IL-18 KO mice had a 4-fold decrease in muscle larvae deposition as compared with WT mice (p < 0.05) (Fig. 1GoB) correlating with the increased worm expulsion rate seen in these animals.

IL-18KO mice exhibit increased MMC responses during T. spiralis infection

Because MMC play an important role in the expulsion of T. spiralis (3, 7, 21) we investigated mast cell recruitment and activity in infected mice from the two groups. The number of MMC in the jejunum of IL-18 KO mice were significantly increased over WT controls at all time points during infection (p < 0.05) (Fig. 2GoA). There was no significant difference in the number of MMC in the uninfected animals (Fig. 2GoA).



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 2. Enhanced worm expulsion in T. spiralis-infected IL-18KO mice is associated with increased numbers of MMC. A, WT and IL-18 KO mice were inoculated with T. spiralis as in Fig. 1Go, and lengths of jejunum were collected on various days p.i., histologically processed, sectioned, and stained with toluidine blue; numbers of MMC per 20 randomly selected villus-crypt units were determined by light microscopy. B, Sera were collected from the same groups of mice as above and analyzed by ELISA for MMCP-1 levels. C, Jejunal sections from the same mice as in A were stained with periodic acid-Schiff, and the number of intestinal goblet cells was enumerated. D, Sections were stained with H&E, and the number of intestinal eosinophils was counted. {blacksquare}, C57BL/6; {square}, IL-18 KO. *, Statistically significant difference between KO and WT (p < 0.05).

 
To determine whether the increased recruitment of mast cells to the small intestine in IL-18 KO mice was also reflected in increased mast cell degranulation, we analyzed the levels of MMCP-1 in serum. IL-18 KO mice expressed high levels of serum MMCP-1 throughout the course of T. spiralis infection (p < 0.05 at all time points p.i. compared with WT mice), indicating that the mast cell hyperplasia seen in IL-18 KO mice consisted of mature and active mast cells. Naive IL-18 KO mice did not express elevated levels of MMCP-1 in their sera (Fig. 2GoB).

We also investigated the number of goblet cells and eosinophils in the small intestine during infection and found no significant difference between the groups (Fig. 2Go, C and D), demonstrating that the absence of IL-18 preferentially stimulates a MMC response.

MLN cells from T. spiralis-infected IL-18 KO mice secrete high levels of Ag-specific Th2 cytokines

The Th2 cytokines IL-4, IL-13, and IL-10 are important in the development and recruitment of MMC (8, 22, 23). To investigate the cytokine response in T. spiralis-infected IL-18 KO and WT mice, MLN cells were harvested at various time points p.i. and restimulated in vitro with T. spiralis Ag. The results in Fig. 3Go demonstrate that IL-18 KO mice develop strong Th2 responses as compared with WT mice. IL-18 KO mice displayed a 30-fold increase in IL-4 secretion as compared with WT mice on day 8 p.i. (IL-18 KO, 7416 ± 435 pg/ml; WT mice, 267 ± 158 pg/ml; p < 0.03; Fig. 3GoA), and a >100-fold increase in IL-13 secretion (IL-18 KO, 84.29 ± 16.22 ng/ml; WT mice, 0.73 ± 0.16 ng/ml; p < 0.03; Fig. 3GoB). The levels of IL-10 were also significantly increased at day 8 p.i. in IL-18 KO mice as compared with WT mice (IL-18 KO, 2427 ± 302 pg/ml; WT mice, 188 ± 126 pg/ml; p < 0.03; Fig. 3GoC).



View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 3. Enhanced resistance to T. spiralis in IL-18 KO mice is associated with increased IL-4, IL-13, and IL-10 secretion. MLN cells from T. spiralis-infected mice were removed at various time points during infection and stimulated in vitro with T. spiralis Ag. Supernatants were analyzed by sandwich ELISA for the presence of IL-4 (A), IL-13 (B), IL-10 (C), and IFN-{gamma} (D). {blacksquare}, C57BL/6; {square}, IL-18 KO. *, Statistically significant difference between KO and WT (p < 0.05).

 
IL-18 KO mice show reduced Th1 responses during T. spiralis infection

To investigate whether the strong increase in Th2 responses seen in the IL-18 KO mice was reflected in a similar decrease in Th1 response, we measured the levels of IFN-{gamma}. The secretion of IFN-{gamma} was significantly reduced in IL-18 KO as compared with WT mice on day 8 p.i. (IL-18 KO, 30.4 ± 16 ng/ml; WT mice, 439 ± 165 ng/ml; p < 0.03; Fig. 3GoD)

In vivo treatment with rIL-18 delays T. spiralis expulsion in NIH mice and increase muscle larvae burdens

The effect of exogenous IL-18 was investigated by treating T. spiralis-infected NIH mice with daily i.p. injections of 200 ng rIL-18 from day 0 to day 10 p.i. NIH mice are fast responders to T. spiralis infection and have normally completed worm expulsion around day 10–14 p.i. Control NIH mice treated with PBS started to expel the worms at day 7 p.i., whereas the rIL-18-treated group still exhibited full worm burden at this time point (Fig. 4GoA; p < 0.02). Ten days p.i., the PBS-treated controls had almost completed expulsion, whereas the rIL-18-treated animals still had significantly higher worm burdens (Fig. 4GoA; p < 0.02). The expulsion process was completed in both groups by day 13 p.i. (Fig. 4GoA).



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 4. In vivo treatment with rIL-18 delays T. spiralis expulsion and increase muscle larval burden. A, NIH mice were inoculated orally with 300 T. spiralis muscle larvae. One group received PBS injections, and one group were injected with 200 ng rIL-18 daily. Mice were sacrificed, and adult worms were counted at the time points indicated. B, NIH mice were inoculated and injected as above, and the number of muscle larvae was determined 30 days later. *, Statistically significant difference between rIL-18-treated and PBS-treated mice (p < 0.05).

 
To investigate the biological significance of the delayed expulsion observed in the rIL-18-treated animals, skeletal muscle larvae burdens were assessed at 30 days p.i. The group that received rIL-18 treatment had a 2-fold higher number of muscle larvae than did the PBS-treated control group (p < 0.02), demonstrating that IL-18 plays an important biological role in the outcome of T. spiralis infection in vivo (Fig. 4GoB).

rIL-18 treatment inhibits T. spiralis-induced mastocytosis in vivo

The numbers of MMC in the jejunum of rIL-18-treated mice were significantly decreased at day 7 p.i. as compared with PBS-treated controls (p < 0.05; Fig. 5GoA). There was no significant difference in mast cell numbers at any other time point. Furthermore, the levels of MMCP-1 in serum were also significantly decreased in the rIL-18-treated group as compared with PBS-treated controls on days 4, 7, and 13 (p < 0.05) (Fig. 5GoB). Taken together, these data demonstrate that in vivo treatment with rIL-18 inhibits MMC recruitment as well as maturation and/or activation.



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 5. In vivo treatment with rIL-18 results in reduced numbers of MMC and reduced levels of MMCP-1. A, NIH mice were inoculated and treated as in Fig. 4Go, and lengths of jejunum were collected on various days p.i., histologically processed, sectioned, and stained with toluidine blue; numbers of MMC per 20 randomly selected villus-crypt units were determined by light microscopy. B, Sera were collected from the same groups of mice as above and analyzed by ELISA for MMCP-1 levels. C, Jejunal sections from the same mice as in A were stained with periodic acid-Schiff, and the number of intestinal goblet cells were enumerated. D, Sections were stained with H&E, and the number of intestinal eosinophils was counted as above. {blacksquare}, PBS; , rIL-18. *, Statistically significant difference between rIL-18-treated and PBS-treated mice (p < 0.05).

 
We also investigated the effect of in vivo rIL-18 treatment on the number of goblet cells and eosinophils during the infection. The in vivo treatment with rIL-18 had no significant effect on the number of goblet cells (Fig. 5GoC), but a significant increase in the number of intestinal eosinophils were detected in rIL-18-treated animals on day 4 p.i. as compared with PBS-treated controls (Fig. 5GoD; p < 0.02). There was no significant difference in the number of eosinophils at any other time point during the infection (Fig. 5GoD).

In vivo treatment with rIL-18 inhibits lymph node secretion of IL-13 and IL-10 whereas IL-4 and IFN-{gamma} remain unaltered

When cytokine secretion from Ag-stimulated MLN cultures were examined, the results show that the PBS-treated NIH mice develop strong Th2 responses during the course of T. spiralis infection (Fig. 6Go). The rIL-18-treated NIH mice, however, had significantly reduced secretion of IL-13 on days 4 and 7 p.i. (p < 0.02 on day 4 and p < 0.04 on day 7; Fig. 6GoB) and IL-10 at day 4 p.i. (p < 0.04; Fig. 6GoC) as compared with the PBS-treated controls. There was no significant decrease in the amount of secreted IL-4 at any time point (Fig. 6GoA). Ag-specific IFN-{gamma} secretion was detected in both groups at day 4 p.i., but thereafter the levels of IFN-{gamma} decreased to low levels. The levels of IFN-{gamma} were not significantly different between the groups at any time point (Fig. 6GoD).



View larger version (36K):
[in this window]
[in a new window]
  		FIGURE 6. In vivo treatment with rIL-18 results in decreased IL-13 and IL-10 secretion. MLN cells from PBS ({blacksquare})- or rIL-18 ()-treated T. spiralis-infected NIH mice were removed at various time points during infection and stimulated in vitro with T. spiralis Ag. Supernatants were analyzed by sandwich ELISA for the presence of IL-4 (A), IL-13 (B), IL-10 (C), and IFN-{gamma} (D). *, Statistically significant difference between rIL-18-treated and PBS-treated mice (p < 0.05).

 
In vivo treatment with rIL-18 results in decreased levels of IL-13, IL-9, and IL-10 mRNA at the site of infection

To investigate the kinetics of the cytokine response at the site of infection, the cytokine mRNA levels in the small intestine were analyzed by RPA. IL-18-treated mice had significantly reduced expression of intestinal IL-13 mRNA on both days 4 and 7 p.i. (p < 0.04 for both time points; Fig. 7GoB) and reduced expression of IL-9 and IL-10 at day 7 p.i. (p < 0.04 for both IL-9 and IL-10; Fig. 7Go, C and D). The levels of IFN-{gamma} mRNA never increased significantly over the levels seen in uninfected controls in either rIL-18-treated or PBS-treated mice (Fig. 7GoE).



View larger version (25K):
[in this window]
[in a new window]
  		FIGURE 7. In vivo treatment with rIL-18 results in decreased levels of IL-13, IL-9, and IL-10 mRNA in the intestine. NIH mice were inoculated and treated as in Fig. 4Go, mRNA was isolated from jejunal samples, and the mRNA levels for IL-4 (A), IL-13 (B), IL-9 (C), IL-10 (D), and IFN-{gamma} (E) were analyzed by RPA. mRNA were normalized with respect to the housekeeping gene GAPDH. Results are expressed as fold induction over naive controls. *, Statistically significant difference between rIL-18-treated () and PBS-treated ({blacksquare}) mice (p < 0.05).

 
The inhibitory effect of IL-18 on T. spiralis expulsion is IFN-{gamma} independent in vivo

To confirm that the effects of IL-18 seen in vivo during T. spiralis infection were not mediated through the induction of IFN-{gamma}, we treated infected IFN-{gamma} KO mice with daily injections of rIL-18 (200 ng/mouse). The control group received PBS injections. Worm burdens were assessed and found to be significantly higher at days 8 and 12 p.i. in the rIL-18-treated group (p < 0.04 for day 8 and p < 0.03 for day 12 p.i.; Fig. 8GoA). This was also reflected in the increased number of encysted muscle larvae detected at day 30 p.i. (p < 0.01; Fig. 8GoB) as well as in a significant decrease in MMC numbers at days 12 and 15 p.i. (p < 0.04 for days 12 and 15 p.i.; Fig. 8GoC). Thus, the data confirm that the effects of IL-18 in promoting worm survival and fecundity is IFN-{gamma} independent in vivo.



View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 8. The in vivo effect of IL-18 is IFN-{gamma}-independent. A, IFN-{gamma} KO mice were inoculated orally with 300 T. spiralis muscle larvae. One group received PBS injections and one group were injected with 200 ng rIL-18 daily. Mice were sacrificed, and adult worms were counted at the time points indicated. B, IFN-{gamma} KO mice were inoculated and injected as above, and the number of muscle larvae was determined 30 days later. C, Lengths of jejunum were collected on various days p.i. and histologically processed, and the number of MMC per 20 randomly selected villus-crypt units was determined by light microscopy. *, Statistically significant difference between rIL-18-treated and PBS-treated mice (p < 0.05).

 
rIL-18-treated IFN-{gamma} KO mice secrete reduced levels of Th2 cytokines

When the Ag-specific cytokine responses were analyzed, the results demonstrated that the rIL-18-treated mice secreted significantly reduced levels of Ag-specific IL-13 on days 8 and 12 p.i. as compared with the PBS-treated controls (p < 0.04 on days 8 and 12; Fig. 9GoB). Ag-specific IL-4 and IL-10 secretion was significantly reduced in the rIL-18 treated group at day 12 p.i. (p < 0.04; Fig. 9Go, A and C). These results clearly demonstrate that IL-18 can inhibit Th2 cytokine responses in the absence of IFN-{gamma}.



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 9. IFN-{gamma} KO mice treated with rIL-18 secrete reduced levels of IL-4, IL-13, and IL-10. MLN cells from PBS-treated ({blacksquare}) or rIL-18-treated () T. spiralis-infected IFN-{gamma} KO mice were removed at various time points during infection and stimulated in vitro with T. spiralis Ag. Supernatants were analyzed by sandwich ELISA for the presence of IL-4 (A), IL-13 (B), and IL-10 (C). *, Statistically significant difference between rIL-18-treated and PBS-treated mice (p < 0.05).

 
IL-18 inhibits proliferation and differentiation of BMMC in vitro

To further investigate whether IL-18 has a direct effect on mast cell differentiation, we cultured BMMC with varying doses of rIL-18 added to the culture medium. After 25 days in culture, the cells were determined to be 95% mast cells by toluidine blue staining of cytospins for all culture conditions used (data not shown).

When the cell yield for each condition was determined, the data revealed that the addition of rIL-18 resulted in a dose-dependent decrease in the number of cells per well (Fig. 10GoA). There was no difference in the morphology of the mast cells, and there was no increase in any other cell type in the wells (data not shown).



View larger version (12K):
[in this window]
[in a new window]
  		FIGURE 10. IL-18 inhibits mast cell proliferation and cytokine secretion in vitro. A, Murine bone marrow cells were grown in IL-3-containing medium for 25 days, and the number of mast cells per well was determined. B, The BMMC were then washed, replated at equal numbers per well, and stimulated with PMA-ionomycin, and the supernatant was analyzed for MMCP-1. C, The number of IL-4-producing BMMC was also enumerated by ELISPOT.

 
We also analyzed the level of maturation of the different BMMC. The mast cells from the different conditions were replated at equal numbers per well and stimulated with PMA-ionomycin for 48 h and the supernatants were analyzed for MMCP-1 secretion. As shown in Fig. 10GoB, there was no difference in the levels of MMCP-1 secreted by the BMMC, indicating that all the mast cells were mature regardless of whether or not they were grown with IL-18. However, when we analyzed the number of IL-4-producing mast cells by ELISPOT, there was a significant dose-dependent decrease in the number of IL-4-producing cells (Fig. 10GoC). When rIL-18 was added to already mature BMMC (after 25 days of culture) for 48 h, no effect was seen on cell numbers, MMCP-1 secretion or IL-4 production (data not shown). Taken together, these results demonstrate that IL-18 is effective in inhibiting mast cell responses in several ways, including reduced proliferation and the inhibition of cytokine secretion, whereas other responses, such as protease secretion, remains unaffected and that the effect of IL-18 appears to be on mast cell precursors rather than on mature mast cells.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
IL-18 is an important component in the development of a Th1 response but is unable to initiate a Th1 response without the presence of IL-12 (10, 11, 12). However, recent findings indicate that the in vivo effects of IL-18 now extend to include direct antimicrobial and immunomodulatory effects that are IFN-{gamma} and/or IL-12 independent (17, 24). The data presented here provide the first report that IL-18 regulates the development of MMC and Th2 responses in the small intestine. Furthermore, we demonstrate that this effect is independent of IFN-{gamma} and that it has a significant impact on the development of intestinal immunity against T. spiralis infection.

Mouse strains can be divided into slow or fast responders according to their ability to expel T. spiralis from the small intestine (21, 25). The speed of expulsion is clearly correlated with the capability to develop MMC hyperplasia (21) and blocking mast cell development by anti-stem cell factor treatment or by blocking the c-kit receptor in vivo significantly delays worm expulsion (2, 3). Furthermore, mast cell-deficient W/Wv mice (4) as well as MMCP-1 KO mice (5) display delayed expulsion, demonstrating that MMC are actively involved in the expulsion of adult T. spiralis worms. The exact mechanism of expulsion is not clear but is known to be dependent on a Th2 type of response (involving IL-4, IL-13, and IL-9) that leads to the activation of MMC (1, 2, 3, 7, 8, 9).

Because IL-18 is known as a potent inducer of IFN-{gamma} (10, 11, 12, 13), we wanted to investigate the importance of this cytokine during a T. spiralis infection in vivo. When IL-18 KO and WT (C57BL/6) mice were infected with T. spiralis, the IL-18 KO mice rapidly expelled the worms; as a result, the muscle larvae burdens were significantly decreased in IL-18 KO mice as compared with WT mice. Thus, IL-18 may promote the survival of T. spiralis in vivo. Interestingly, when IL-12KO mice were infected in parallel, these mice were no different from WT mice in terms of speed of worm expulsion or in the number of encysted muscle larvae, indicating that endogenous IL-12 does not play a major role in delaying T. spiralis expulsion. Previous work has shown that vivo administration of rIL-12 to Nippostrongylus brasiliensis-infected mice delay worm expulsion and inhibit mastocytosis in an IFN-{gamma}-dependent manner (26). Thus, exogenous IL-12 may inhibit mast cell development through its capacity to induce IFN-{gamma} responses rather than acting directly on mast cell precursors.

When we investigated the cytokine basis for the observed differences in the kinetics of worm expulsion between IL-18 KO and WT mice, the results showed that the rapid expulsion seen in IL-18 KO mice correlated well with high levels of Ag-specific Th2 cytokine secretion (IL-4, IL-13, and IL-10). The levels of IFN-{gamma} secretion from IL-18 KO mice were significantly lower than those from WT mice in agreement with other studies (18).

NIH mice are fast responders in terms of T. spiralis expulsion (the expulsion process is usually completed around day 10–12 p.i.) (21, 25), whereas the slow responder strain C57BL/6 does not complete expulsion until around day 15–18 p.i. However, when NIH mice were treated with daily injections of rIL-18, they showed significantly delayed expulsion and increased numbers of muscle larvae. This finding, together with the IL-18 KO data, demonstrates that administration of rIL-18 to a fast responder strain, such as NIH, can turn it into a slow responder strain, whereas removing IL-18 from a slow responder strain (C57BL/6) will turn it into a fast responder (IL-18 KO). When NIH mice were treated with rIL-18 in vivo during T. spiralis infection, a significant decrease in IL-13 and IL-10 secretion was detected during early time points of the infection in the MLN. When the local cytokine mRNA expression of the small intestine was analyzed by RPA, a similar decrease could be detected for IL-13, IL-10, and IL-9 in situ. The levels of IFN-{gamma} secretion in MLN cultures were no different between the rIL-18-treated group and the PBS-treated controls, and IFN-{gamma} mRNA did not increase in the small intestine at any time point p.i. in either group. Taken together, the data show that the IL-18-induced suppression of Th2 responses was not linked to an increase in IFN-{gamma}, either in the MLN or locally at the site of infection, indicating that the effect might be IFN-{gamma} independent. To confirm this, we infected IFN-{gamma} KO mice and treated them with rIL-18 or PBS injections. IFN-{gamma} KO mice are highly resistant to T. spiralis infection and expel the parasites quickly under normal conditions. In vivo treatment with rIL-18, however, delayed expulsion of the worms, increased muscle larvae burdens, and suppressed Th2 cytokine secretion significantly, clearly demonstrating that the in vivo effects of IL-18 on gastrointestinal nematode infections is IFN-{gamma} independent, in agreement with our previous studies (17).

The maturation and development of MMC are largely dependent on Th2 cytokines such as IL-3, IL-4, IL-13, IL-9, and, in particular, IL-10 (8, 22, 23, 27). T. spiralis-infected IL-18 KO mice developed a high level of mastocytosis in the small intestine during infection, correlating with the enhanced expulsion rate of the parasites and the increase in Th2 cytokine secretion. Injections of rIL-18 into normal mice during infection significantly decreased the mastocytosis as well as the levels of Th2 cytokines. This was also true in rIL-18-treated IFN-{gamma} KO mice. Goblet cell hyperplasia was not affected by IL-18 treatment, and the effect on eosinophil recruitment was only marginal, demonstrating that the effect of IL-18 appears to be specific for MMC in vivo. Both mast cells and basophils express IL-18R (28), and human intestinal mast cells have been shown to express IL-18 (29), which may possibly function as a negative feedback mechanism. To confirm that IL-18 has a direct regulatory effect on MMC, we cultured BMMC with rIL-18 in vitro. Bone marrow cells from normal mice were cultured to BMMCs according to standard methodology with varying doses of rIL-18 present in the cultures throughout the experiment. The effect of adding rIL-18 to the developing BMMC was pronounced. IL-18 inhibited cell proliferation and cytokine production in a dose-dependent manner but did not affect the production of MMCP-1. These results demonstrate that IL-18 is effective in inhibiting mast cell responses in several ways, including reduced proliferation and the inhibition of cytokine secretion, whereas other responses, such as protease secretion, are unaffected. IL-4 enhances mast cell proliferation (30), and because we detected a concomitant decrease in the number of IL-4-producing mast cells and cell yield in the rIL-18-treated BBMC cultures, this may represent a possible inhibitory pathway of IL-18 on mast cell development. When we added rIL-18 to already mature BMMC cultures, there was no detectable effect on cell yield, MMCP-1 secretion, or IL-4 production (data not shown), indicating that IL-18 acts on precursors rather than on mature mast cells. MMC are believed to be immature when they arrive in the intestine during the first week of T. spiralis infection. In the intestine, they then become mature and express MMCP-1 (31, 32). Thus, IL-18 may act locally in the intestine to inhibit mast cell maturation but may also already act at the level of mast cell precursors in the bone marrow.

In this report, we provide new information on IL-18 as a key regulator of MMC development and Th2 responses in the small intestine. This study provides, for the first time, conclusive evidence that IL-18 has a direct effect on MMC responses and that IL-18 plays a significant role in the development of pathology caused by gastrointestinal nematode infections. This is the first report showing the importance of IL-18 in regulating intestinal mast cell functions in vivo, and these results extend our knowledge of the cytokine-mediated regulation of intestinal inflammation. The data may thus provide important information for the design of rational therapies against parasitic infections, allergic reactions, and inflammation of the intestine and other mucosal sites.


   Acknowledgments
 
We thank Neil Humphreys and Ann Lowe for excellent technical assistance and Prof. Nancy Rothwell for kindly providing animals.


   Footnotes
 
1 This work was supported by The Wellcome Trust and the Biotechnology and Biological Sciences Research Council. Back

2 Address correspondence and reprint requests to Dr. Helena Helmby, School of Biological Sciences, Stopford Building 3.239, University of Manchester, Manchester M13 9PT, U.K. E-mail address: helena.e.helmby{at}man.ac.uk Back

3 Abbreviations used in this paper: MLN, mesenteric lymph node; MMC, mucosal mast cell; KO, knockout; p.i., postinfection; BMMC, bone marrow-derived mast cell; MMCP-1, MMC protease-1; WT, wild type; RPA, RNase protection assay. Back

Received for publication April 29, 2002. Accepted for publication June 27, 2002.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Grencis, R. K., L. Hultner, K. J. Else. 1991. Host protective immunity to Trichinella spiralis in mice: activation of Th cell subsets and lymphokine secretion in mice expressing different response phenotypes. Immunology 74:329.[Medline]
  2. Grencis, R. K., K. J. Else, J. F. Huntley, S. I. Nishikawa. 1993. The in vivo role of stem cell factor (c-kit ligand) on mastocytosis and host protective immunity to the intestinal nematode Trichinella spiralis in mice. Parasite Immunol. 15:55.[Medline]
  3. Donaldson, L. E., E. Schmitt, J. F. Huntley, G. F. J. Newlands, R. K. Grencis. 1995. A critical role for stem cell factor and c-kit in host protective immunity to an intestinal helminth. Int. Immunol. 8:559.[Abstract/Free Full Text]
  4. Kamiya, M., Y. Oku, H. Itayama, M. Obayashi. 1985. Prolonged expulsion of adult Trichinella spiralis and eosinophil infiltration in mast cell-deficient W/Wv mice. J. Helminthol. 59:233.[Medline]
  5. Knight, P. A., S. H. Wright, C. E. Lawrence, Y. Y. W. Paterson, H. R. P. Miller. 2000. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192:1849.[Abstract/Free Full Text]
  6. Finkelman, F. D., T. Shea-Donohue, J. Goldhill, C. A. Sullivan, S. C. Morris, K. B. Madden, W. C. Gause, J. F. Urban. 1997. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu. Rev. Immunol. 15:505.[Medline]
  7. Faulkner, H., N. Humphreys, J.-C. Renauld, J. Van Snick, R. Grencis. 1997. Interleukin-9 is involved in host protective immunity to intestinal nematode infection. Eur. J. Immunol. 27:2536.[Medline]
  8. Urban, J. F., L. Schopf, S. C. Morris, T. Orekhova, K. B. Madden, C. J. Betts, H. R. Gamble, C. Byrd, D. Donaldson, K. Else, F. D. Finkelman. 2000. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J. Immunol. 164:2046.[Abstract/Free Full Text]
  9. Khan, W. I., B. A. Vallance, P. Blennerhassett, Y. Deng, E. F. Verdu, K. I. Matthaei, S. M. Collins. 2001. Critical role for signal transducer and activator of transcription factor 6 in mediating intestinal muscle hypercontractility and worm expulsion in Trichinella spiralis-infected mice. Infect. Immun. 69:838.[Abstract/Free Full Text]
  10. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al 1995. Cloning of a new cytokine that induces IFN-{gamma} production by T cells. Nature 378:88.[Medline]
  11. Ahn, H.-Y., S. Maruo, M. Tomura, J. Mu, T. Hamakoa, K. Nakanishi, S. Clark, M. Kurimoto, H. Okamura, H. Fujiwara. 1997. A mechanism underlying synergy between IL-12 and IFN-{gamma}-inducing factor in enhanced production of IFN-{gamma}. J. Immunol. 159:2125.[Abstract/Free Full Text]
  12. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, A. O’Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-{gamma} production and activates IRAK and NF{kappa}B. Immunity 7:571.[Medline]
  13. Kohno, K., J. Kataoka, T. Ohtsuki, Y. Suemoto, I. Okamoto, M. Usui, M. Ikeda, M. Kurimoto. 1997. IFN-{gamma}-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1541.[Abstract]
  14. Pizarro, T. T., M. H. Michie, M. Bentz, J. Woraratanadharm, Jr M. S. Smith, E. Foley, C. A. Moskaluk, S. J. Bickston, F. Cominelli. 1999. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn’s disease: expression and localization in intestinal mucosal cells. J. Immunol. 162:6829.[Abstract/Free Full Text]
  15. Monteleone, G., F. Trapasso, T. Parrello, L. Biancone, A. Stella, R. Iuliano, F. Luzza, A. Fusco, F. Pallone. 1999. Bioactive IL-18 expression is up-regulated in Crohn’s disease. J. Immunol. 163:143.[Abstract/Free Full Text]
  16. Tomita, T., A. M. Jackson, N. Hida, M. Hayat, M. F. Dixon, T. Shimoyama, A. T. R. Axon, P. A. Robinson, J. E. Crabtree. 2001. Expression of interleukin-18, a Th1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J. Infect. Dis. 183:620.[Medline]
  17. Helmby, H., K. Takeda, S. Akira, R. K. Grencis. 2001. Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J. Exp. Med. 194:355.[Abstract/Free Full Text]
  18. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.[Medline]
  19. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-{gamma} production and type 1 cytokine responses. Immunity 4:471.[Medline]
  20. Wakelin, D., M. M. Wilson. 1977. Transfer of immunity to Trichinella spiralis in the mouse with mesenteric lymph node cells in donors, and expression of immunity in recipients. Parasitology 74:215.[Medline]
  21. Tuohy, M., D. A. Lammas, D. Wakelin, J. F. Huntley, G. F. J. Newlands, H. R. P. Miller. 1990. Functional correlations between mucosal mast cell activity and immunity to Trichinella spiralis in high and low responder mice. Parasite Immunol. 12:675.[Medline]
  22. Madden, K. B., J. F. Urban, H. J. Ziltener, J. W. Schrader, F. D. Finkelman, I. M. Katona. 1991. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147:1387.[Abstract]
  23. Ghildyal, N., H. P. McNeil, S. Stechschulte, K. F. Austen, D. Silberstein, M. F. Gurish, L. L. Somerville, R. L. Stevens. 1992. IL-10 induces transcription of the gene for mouse mast cell protease-1, a serine protease preferentially expressed in mucosal mast cells of Trichinella spiralis-infected mice. J. Immunol. 149:2123.[Abstract]
  24. Neighbors, M., X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, A. O’Garra. 2001. A critical role for Interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on interferon {gamma} production. J. Exp. Med. 194:343.[Abstract/Free Full Text]
  25. Lammas, D. A., D. Wakelin, L. A. Mitchell, M. Tuohy, K. J. Else, R. K. Grencis. 1992. Genetic influences upon eosinophilia in mice infected with Trichinella spiralis. Parasitology 105:117.
  26. Finkelman, F. D., K. B. Madden, A. W. Cheever, I. M. Katona, S. C. Morris, M. K. Gately, B. R. Hubbard, W. C. Gause, J. F. Urban. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites. J. Exp. Med. 179:1563.[Abstract/Free Full Text]
  27. Eklund, K. K., N. Ghildyal, K. F. Austen, R. L. Stevens. 1993. Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J. Immunol. 151:4266.[Abstract]
  28. Yoshimoto, T., H. Tsutsui, K. Tominaga, K. Hoshino, H. Okamura, S. Akira, W. E. Paul, K. Nakanishi. 1999. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc. Natl. Acad. Sci. USA 96:13962.[Abstract/Free Full Text]
  29. Lorenz, A., S. Schwengberg, G. Sellge, M. P. Manns, S. C. Bischoff. 2000. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J. Immunol. 164:43.[Abstract/Free Full Text]
  30. Bischoff, S. C., G. Sellge, A. Lorenz, W. Sebald, R. Raab, M. P. Manns. 1999. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc. Natl. Acad. Sci. USA 98:8080.
  31. Friend, D. S., N. Ghildyal, K. F. Austen, M. F. Gurish, R. Matsumoto, R. L. Stevens. 1996. Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype. J. Cell Biol. 135:279.[Abstract/Free Full Text]
  32. Friend, D. S., N. Ghildyal, M. F. Gurish, J. Hunt, X. Hu, K. F. Austen, R. L. Stevens. 1998. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis. J. Immunol. 160:5537.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. R. Hepworth and R. K. Grencis
Disruption of Th2 Immunity Results in a Gender-Specific Expansion of IL-13 Producing Accessory NK Cells during Helminth Infection
J. Immunol., September 15, 2009; 183(6): 3906 - 3914.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. X. Ierna, H. E. Scales, C. Mueller, and C. E. Lawrence
Transmembrane Tumor Necrosis Factor Alpha Is Required for Enteropathy and Is Sufficient To Promote Parasite Expulsion in Gastrointestinal Helminth Infection
Infect. Immun., September 1, 2009; 77(9): 3879 - 3885.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Helmby
Gastrointestinal Nematode Infection Exacerbates Malaria-Induced Liver Pathology
J. Immunol., May 1, 2009; 182(9): 5663 - 5671.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Z. Wiener, P. Pocza, M. Racz, G. Nagy, G. Tolgyesi, V. Molnar, J. Jaeger, E. Buzas, E. Gorbe, Z. Papp, et al.
IL-18 induces a marked gene expression profile change and increased Ccl1 (I-309) production in mouse mucosal mast cell homologs
Int. Immunol., December 1, 2008; 20(12): 1565 - 1573.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. A. Knight, J. K. Brown, S. H. Wright, E. M. Thornton, J. A. Pate, and H. R.P. Miller
Aberrant Mucosal Mast Cell Protease Expression in the Enteric Epithelium of Nematode-Infected Mice Lacking the Integrin {alpha}v{beta}6, a Transforming Growth Factor-{beta}1 Activator
Am. J. Pathol., October 1, 2007; 171(4): 1237 - 1248.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. P. Lewkowich, J. D. Rempel, and K. T. HayGlass
Prevention of Allergen-Specific, Th2-Biased Immune Responses In Vivo: Role of Increased IL-12 and IL-18 Responsiveness
J. Immunol., October 15, 2005; 175(8): 4956 - 4962.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Y. Sasaki, T. Yoshimoto, H. Maruyama, T. Tegoshi, N. Ohta, N. Arizono, and K. Nakanishi
IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity
J. Exp. Med., September 6, 2005; 202(5): 607 - 616.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Helmby and R. K. Grencis
IFN-{gamma}-Independent Effects of IL-12 During Intestinal Nematode Infection
J. Immunol., October 1, 2003; 171(7): 3691 - 3696.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. K. Bliss, A. Alcaraz, and J. A. Appleton
IL-10 Prevents Liver Necrosis During Murine Infection with Trichinella spiralis
J. Immunol., September 15, 2003; 171(6): 3142 - 3147.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Helmby, H.
Right arrow Articles by Grencis, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Helmby, H.
Right arrow Articles by Grencis, R. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS